93 related articles for article (PubMed ID: 24703201)
21. Targeting human secretory phospholipase A2 with designed peptide inhibitors for inflammatory therapy.
Wang P; Li Y; Shao Q; Zhou W; Wang K
J Drug Target; 2015 Feb; 23(2):140-6. PubMed ID: 25237841
[TBL] [Abstract][Full Text] [Related]
22. Deciphering the interactions of scopoletin and scopolin from Catunaregam nilotica roots against Naja nigricollis phospholipase A
Salihu M; Hassan LG; Faruq UZ; Yusuf AJ
Toxicon; 2024 May; 243():107732. PubMed ID: 38642905
[TBL] [Abstract][Full Text] [Related]
23. In silico and in vitro neutralization of PLA
Devi A; Namsa ND; Doley R
Int J Biol Macromol; 2020 Dec; 165(Pt A):1066-1078. PubMed ID: 33035526
[TBL] [Abstract][Full Text] [Related]
24. Pyrazolo[3,4-d]pyrimidines as inhibitor of anti-coagulation and inflammation activities of phospholipase A 2 : insight from molecular docking studies.
Yadava U; Singh M; Roychoudhury M
J Biol Phys; 2013 Jun; 39(3):419-38. PubMed ID: 23860918
[TBL] [Abstract][Full Text] [Related]
25. Neutralisation of the pharmacological activities of Bothrops alternatus venom by anti-PLA2 IgGs.
Garcia Denegri ME; Maruñak S; Todaro JS; Ponce-Soto LA; Acosta O; Leiva L
Toxicon; 2014 Aug; 86():89-95. PubMed ID: 24878372
[TBL] [Abstract][Full Text] [Related]
26. Molecular modeling and snake venom phospholipase A2 inhibition by phenolic compounds: Structure-activity relationship.
Alam MI; Alam MA; Alam O; Nargotra A; Taneja SC; Koul S
Eur J Med Chem; 2016 May; 114():209-19. PubMed ID: 26986086
[TBL] [Abstract][Full Text] [Related]
27. Discovery of a new
Sukumaran S; Prasanna VM; Panicker LK; Nair AS; Oommen OV
J Biomol Struct Dyn; 2023 Jul; ():1-14. PubMed ID: 37490072
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of cisplatin and [Pt(dach)Cl2] on the activity of phospholipase A2.
Radisavljević M; Kamčeva T; Bugarčić ŽD; Petković M
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):651-60. PubMed ID: 22424180
[TBL] [Abstract][Full Text] [Related]
29. PLA
Borges RJ; Lemke N; Fontes MRM
Sci Rep; 2017 Nov; 7(1):15514. PubMed ID: 29138410
[TBL] [Abstract][Full Text] [Related]
30. Isolation of a snake venom phospholipase A2 (PLA2) inhibitor (AIPLAI) from leaves of Azadirachta indica (Neem): mechanism of PLA2 inhibition by AIPLAI in vitro condition.
Mukherjee AK; Doley R; Saikia D
Toxicon; 2008 Jun; 51(8):1548-53. PubMed ID: 18466944
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of secreted phospholipase A2 by proanthocyanidins: a comparative enzymological and in silico modeling study.
Lambert JD; Yennawar N; Gu Y; Elias RJ
J Agric Food Chem; 2012 Aug; 60(30):7417-20. PubMed ID: 22779786
[TBL] [Abstract][Full Text] [Related]
32. Lipidomics-based assays coupled with computational approaches can identify novel phospholipase A
Mouchlis VD; Mu C; Hammons R; Dennis EA
Adv Biol Regul; 2020 May; 76():100719. PubMed ID: 32199750
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of the expressions of phospholipase A2 inhibitors in the liver of a venomous snake by its own venom phospholipase A2.
Kinkawa K; Shirai R; Watanabe S; Toriba M; Hayashi K; Ikeda K; Inoue S
Biochem Biophys Res Commun; 2010 May; 395(3):377-81. PubMed ID: 20382116
[TBL] [Abstract][Full Text] [Related]
34. Discovery of novel secretory phospholipase A2 inhibitors using virtual screen.
Qiu S; Chen F; Liu Y; Lai L
Chem Biol Drug Des; 2014 Aug; 84(2):216-22. PubMed ID: 24612767
[TBL] [Abstract][Full Text] [Related]
35. Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A
Mouchlis VD; Morisseau C; Hammock BD; Li S; McCammon JA; Dennis EA
Bioorg Med Chem; 2016 Oct; 24(20):4801-4811. PubMed ID: 27320659
[TBL] [Abstract][Full Text] [Related]
36. Exploring the potent inhibitors and binding modes of phospholipase A2 through in silico investigation.
Mahmud S; Parves MR; Riza YM; Sujon KM; Ray S; Tithi FA; Zaoti ZF; Alam S; Absar N
J Biomol Struct Dyn; 2020 Sep; 38(14):4221-4231. PubMed ID: 31607222
[TBL] [Abstract][Full Text] [Related]
37. A novel pharmacophore model to identify leads for simultaneous inhibition of anti-coagulation and anti-inflammatory activities of snake venom phospholipase A(2).
Wadood A; Ali SA; Sattar R; Lodhi MA; Ul-Haq Z
Chem Biol Drug Des; 2012 Apr; 79(4):431-41. PubMed ID: 22136624
[TBL] [Abstract][Full Text] [Related]
38. Computer-aided drug design of novel PLA2 inhibitor candidates for treatment of snakebite.
Hage-Melim LI; da Silva CH; Semighini EP; Taft CA; Sampaio SV
J Biomol Struct Dyn; 2009 Aug; 27(1):27-36. PubMed ID: 19492860
[TBL] [Abstract][Full Text] [Related]
39. Subunit structure and inhibition specificity of alpha-type phospholipase A2 inhibitor from Protobothrops flavoviridis.
Shimada A; Ohkura N; Hayashi K; Samejima Y; Omori-Satoh T; Inoue S; Ikeda K
Toxicon; 2008 Apr; 51(5):787-96. PubMed ID: 18243268
[TBL] [Abstract][Full Text] [Related]
40. Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and Structure-Activity Relationships.
Mouchlis VD; Limnios D; Kokotou MG; Barbayianni E; Kokotos G; McCammon JA; Dennis EA
J Med Chem; 2016 May; 59(9):4403-14. PubMed ID: 27087127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
